Official Title
Effectiveness of Transcranial Direct Current (tDCS) Treatment in Patients With Persistent Covid Who Present Headaches and Chronic Body Pain.
Brief Summary

This study aims to verify the efficacy / effectiveness of treatment with transcranialdirect therapy (TDCS) in patients with Persistent Covid who present headaches, migrainesand chronic pain, such as arthralgias and myalgias.Transcranial Direct Therapy is used in the field of Physiotherapy and Rehabilitation,with results that prove to be effective for the treatment of patients suffering fromsymptoms such as migraines, headaches, chronic pain, fibromyalgia or chronic neuropathicpain.As can be seen, in the case of patients with Persistent Covid we find several of thesesymptoms, so it is suggested that, if Transcranial Direct Current Therapy (TDCs) isgiving such good results, relieving these symptoms, why can not give such good resultsand help so much in patients with Persistent Covid, If many of the symptoms are the same,even if the origin or cause is different.

Detailed Description

Not Provided

Recruiting
COVID-19
Long Covid
Long Covid19
SARS CoV 2 Infection
Persistent COVID-19
Migraine Disorders
Headaches Chronic
Cluster Headache
Arthralgia
Myalgia
Chronic Pain
Post-COVID-19 Syndrome
Post COVID-19 Condition

Device: Transcranial Direct Current Therapy (tDCS)

Transcranial direct therapy (tDCS) is a non-invasive neuromodulation therapy of the
cerebral cortex, which consists of the application of electrical microcurrents, of
approximately 2mA, through surface electrodes placed on the scalp. Transcranial therapy
(tDCS) produces immediate effects on the ability of neurons to change their electrical
potential.

Each session lasts between 20 and 30 minutes, and approximately 10 consecutive sessions
should be performed. It will be applied through two surface electrodes of 25 to 35 cm2 at
2 mA.

The equipment has a European health certificate (CE), so it is an approved equipment that
complies with all the safety measures for the application of the treatment.

Eligibility Criteria

Inclusion Criteria:

- Patients with Persistent Covid

- Men and women

- All ages from 16 years old

- Patients who passed the Covid in its acute phase in an asymptomatic, mild and severe
way.

Exclusion Criteria:

- Patients without confirmation with positive PCR in the acute phase of Covid-19

- Patients with Persistent Covid who do not have at least one of these symptoms:
migraines, headaches, chronic pain, neuropathic pain, arthralgia, myalgias

- Patients with pacemaker / defibrillator

- Patients with brain implants

- Patients with cranial fractures

- Pregnant

Eligibility Gender
All
Eligibility Age
Minimum: 16 Years ~ Maximum: N/A
Countries
Spain
Locations

Clínica Paiporta
Paiporta, Valencia, Spain

Escuela de Doctorado. Universidad Católica de Valencia San Vicente Mártir. (Doctoral School. Catholic University of Valencia San Vicente Mártir)
Valencia, Spain

Contacts

LAURA GARCÍA MARTÍNEZ
+34691635330
lauragarciamartinez@mail.ucv.es

LAURA GARCÍA MARTÍNEZ, Principal Investigator
Escuela de Doctorado. Universidad Católica de Valencia San Vicente Mártir. (Doctoral School. Catholic University of Valencia San Vicente Mártir)

Fundación Universidad Católica de Valencia San Vicente Mártir
NCT Number
Keywords
Transcranial direct current stimulation
tDCS
Covid Persistente
MeSH Terms
COVID-19
Post-Acute COVID-19 Syndrome
Arthralgia
Myalgia
Cluster Headache
Migraine Disorders
Chronic Pain
Headache